ConductScience.org, home

Paper688279

Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.

Patton TF and 5 others. Cancer Treat Rep, 1978. Cited by 125 papers, by iCite.

Cite this record

ConductScience Library. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. Papers, record 688279. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/688279

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
125
iCite
Relative citation ratio, by iCite
6.71
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Patton TFT F
2Himmelstein KJK J
3Belt RR
4Bannister SJS J
5Sternson LAL A
6Repta AJA J

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
Half-Life
Humans
Infusions, Parenteral
Injections, Intravenous
Protein Binding
Ultracentrifugation

Source PubMed

Download CSV of topics

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.

PMIDTitleJournalYearIn PapersSource
10970685Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer.Br J Cancer2000https://conductscience.org/library/papers/10970685PubMed
8422664Effect of cisplatin upon expression of in vivo immune tumor resistance.Cancer Immunol Immunother1993https://conductscience.org/library/papers/8422664PubMed
7497604Long-term pharmacokinetic behavior of platinum after cisplatin administration.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7497604PubMed
7497595A phase I trial of 5-day continuous infusion cisplatin and interferon alpha.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7497595PubMed
7318146Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7318146PubMed
7272193British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts.Br J Cancer1981https://conductscience.org/library/papers/7272193PubMed
7200547[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].Klin Wochenschr1982https://conductscience.org/library/papers/7200547PubMed
7196299Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II).Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7196299PubMed
7023712Dose-dependent pharmacokinetics and cancer chemotherapy.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7023712PubMed
6883623Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6883623PubMed
6791675In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.Br J Cancer1981https://conductscience.org/library/papers/6791675PubMed
6685578Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6685578PubMed
6682017
A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II).
Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6682017PubMed
6540631Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6540631PubMed
6391659Effect of cis-platinum on human blood monocyte function in vitro.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6391659PubMed
6375139Intestinal and liver toxicity of antineoplastic drugs.West J Med1984https://conductscience.org/library/papers/6375139PubMed
6299598Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6299598PubMed
6189661Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6189661PubMed
6161715Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6161715PubMed
6088712Chemosensitivity of malignant human brain tumors. Preliminary results.J Neurooncol1983https://conductscience.org/library/papers/6088712PubMed

See all 35 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/688279

GET https://conductscience.org/api/papers/v1/688279/cited_by?page=2